PT - JOURNAL ARTICLE AU - Souptik Barua AU - Hesham Elhalawani AU - Stefania Volpe AU - Karine Al Feghali AU - Pei Yang AU - Sweet Ping Ng AU - Baher Elgohari AU - Robin C. Granberry AU - Dennis S. Mackin AU - G. Brandon Gunn AU - Katherine A. Hutcheson AU - Mark S. Chambers AU - Laurence E. Court AU - Abdallah Mohamed AU - Clifton D. Fuller AU - Stephen Y. Lai AU - Arvind Rao TI - Discovering early imaging biomarkers of osteoradionecrosis in oropharyngeal cancer by characterization of temporal changes in computed tomography mandibular radiomic features AID - 10.1101/2020.10.09.20208827 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.09.20208827 4099 - http://medrxiv.org/content/early/2020/10/13/2020.10.09.20208827.short 4100 - http://medrxiv.org/content/early/2020/10/13/2020.10.09.20208827.full AB - Osteoradionecrosis (ORN) is a major side-effect of radiation therapy in oropharyngeal cancer (OPC) patients. In this study, we demonstrate that early prediction of ORN is possible by analyzing the temporal evolution of mandibular subvolumes receiving radiation. For our analysis, we use computed tomography (CT) scans from 21 OPC patients treated with Intensity Modulated Radiation Therapy (IMRT) with subsequent radiographically-proven ≥ grade II ORN, at three different time points: pre-IMRT, 2-months, and 6-months post-IMRT. For each patient, radiomic features were extracted from a mandibular subvolume that developed ORN and a control subvolume that received the same dose but did not develop ORN. We used a Multivariate Functional Principal Component Analysis (MFPCA) approach to characterize the temporal trajectories of these features. The proposed MFPCA model performs the best at classifying ORN vs Control subvolumes with an area under curve (AUC) = 0.74 (95% confidence interval (C.I.): 0.61-0.90), significantly outperforming existing approaches such as a pre-IMRT features model or a delta model based on changes at intermediate time points, i.e. at 2- and 6-month follow-up. This suggests that temporal trajectories of radiomics features derived from sequential pre- and post-RT CT scans can provide markers that are correlates of RT-induced mandibular injury, and consequently aid in earlier management of ORN.Competing Interest StatementThe authors have declared no competing interest.Funding StatementS.B. and A.R. were supported by CCSG Bioinformatics Shared Resource P30 CA016672, CPRIT RP170719, CPRIT RP150578, NCI 1R37CA214955-01A1, a gift from Agilent technologies, and a Research Scholar Grant from the American Cancer Society (RSG-16-005-01). A.R. is a member of Voxel Analytics, LLC, reports receiving other commercial research support from Agilent Technologies. H.E. was supported in part by the philanthropic donations from the Family of Paul W. Beach to Dr. G. Brandon Gunn, MD. H.E. and C.D.F. receive funding and project-relevant salary support from NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007-10). This research is supported by the Andrew Sabin Family Foundation; C.D.F. is a Sabin Family Foundation Fellow. C.D.F., S.Y.L., and A.S.R.M. receive funding and project-relevant salary support from the National Institutes of Health (NIH), including: National Institute for Dental and Craniofacial Research Award (1R01DE025248-01/R56DE025248-01). C.D.F., S.Y.L., K.A.H., and A.S.R.M. receive funding and project-relevant salary support from NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148-01). C.D.F. and A.S.R.M. receive funding and project-relevant salary support from National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute [51] Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825-01). C.D.F. receive funding and project-relevant salary support from NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672) and National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787). C.D.F. has received direct industry grant support and travel funding from Elekta AB. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:M.D Anderson Cancer Center IRB RCR-03-800All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesClinical dataset is not available as it includes personal health identifiers (PHI). It is possible for de-identified data to be made available upon reasonable request.